BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 21401626)

  • 21. Oocyte donation--implications for fertility treatment in the nineties.
    Dean NL; Edwards RG
    Curr Opin Obstet Gynecol; 1994 Apr; 6(2):160-5. PubMed ID: 8193256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attitudes of different groups of women in Sweden to oocyte donation and oocyte research.
    Westlander G; Janson PO; Tägnfors U; Bergh C
    Acta Obstet Gynecol Scand; 1998 Mar; 77(3):317-21. PubMed ID: 9539279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients.
    Grifo JA; Noyes N
    Fertil Steril; 2010 Feb; 93(2):391-6. PubMed ID: 19439285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregnancies in women with Turner's syndrome.
    Hovatta O
    Ann Med; 1999 Apr; 31(2):106-10. PubMed ID: 10344582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The acceptability of posthumous human ovarian tissue donation in Utah.
    Mizukami A; Peterson CM; Huang I; Cook C; Boyack LM; Emery BR; Carrell DT
    Hum Reprod; 2005 Dec; 20(12):3560-5. PubMed ID: 16155082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relevance of assisted hatching in an oocyte donation programme using egg cryobanking: a prospective randomised study.
    Figueira Rde C; Braga DP; Setti AS; Iaconelli A; Borges E
    Eur J Obstet Gynecol Reprod Biol; 2012 Sep; 164(1):48-51. PubMed ID: 22672993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Male age negatively impacts embryo development and reproductive outcome in donor oocyte assisted reproductive technology cycles.
    Frattarelli JL; Miller KA; Miller BT; Elkind-Hirsch K; Scott RT
    Fertil Steril; 2008 Jul; 90(1):97-103. PubMed ID: 17765235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation.
    Styne-Gross A; Elkind-Hirsch K; Scott RT
    Fertil Steril; 2005 Jun; 83(6):1629-34. PubMed ID: 15950629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R
    Fertil Steril; 2007 Jul; 88(1):237-9. PubMed ID: 17296193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of myomectomy on the outcome of assisted reproductive technologies.
    Surrey ES; Minjarez DA; Stevens JM; Schoolcraft WB
    Fertil Steril; 2005 May; 83(5):1473-9. PubMed ID: 15866587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy wastage and reproductive aging: the oocyte donation model.
    Sauer MV
    Curr Opin Obstet Gynecol; 1996 Jun; 8(3):226-9. PubMed ID: 8818535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective, randomized, controlled trial comparing three different gonadotropin regimens in oocyte donors: ovarian response, in vitro fertilization outcome, and analysis of cost minimization.
    Melo M; Bellver J; Garrido N; Meseguer M; Pellicer A; Remohí J
    Fertil Steril; 2010 Aug; 94(3):958-64. PubMed ID: 19931075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes.
    Chian RC; Huang JY; Gilbert L; Son WY; Holzer H; Cui SJ; Buckett WM; Tulandi T; Tan SL
    Fertil Steril; 2009 Jun; 91(6):2391-8. PubMed ID: 18579139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversing the natural decline in human fertility. An extended clinical trial of oocyte donation to women of advanced reproductive age.
    Sauer MV; Paulson RJ; Lobo RA
    JAMA; 1992 Sep; 268(10):1275-9. PubMed ID: 1507373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of aging on fertility.
    Speroff L
    Curr Opin Obstet Gynecol; 1994 Apr; 6(2):115-20. PubMed ID: 8193249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observational clinical follow-up of oocyte cryopreservation using a slow-freezing method with 1,2-propanediol plus sucrose followed by ICSI.
    Chen SU; Lien YR; Chen HF; Chang LJ; Tsai YY; Yang YS
    Hum Reprod; 2005 Jul; 20(7):1975-80. PubMed ID: 15790604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oocyte donation and endometriosis: What are the lessons?
    Hauzman EE; Garcia-Velasco JA; Pellicer A
    Semin Reprod Med; 2013 Mar; 31(2):173-7. PubMed ID: 23446865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The significance of premature luteinization in an oocyte-donation programme.
    Melo MA; Meseguer M; Garrido N; Bosch E; Pellicer A; Remohí J
    Hum Reprod; 2006 Jun; 21(6):1503-7. PubMed ID: 16648153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter observational study on slow-cooling oocyte cryopreservation: clinical outcome.
    Borini A; Levi Setti PE; Anserini P; De Luca R; De Santis L; Porcu E; La Sala GB; Ferraretti A; Bartolotti T; Coticchio G; Scaravelli G
    Fertil Steril; 2010 Oct; 94(5):1662-8. PubMed ID: 20047739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Report of four donor-recipient oocyte cryopreservation cycles resulting in high pregnancy and implantation rates.
    Barritt J; Luna M; Duke M; Grunfeld L; Mukherjee T; Sandler B; Copperman AB
    Fertil Steril; 2007 Jan; 87(1):189.e13-7. PubMed ID: 17094985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.